Last year's Budget set aside £2.1 billion for NHS IT, and the autumn statement confirmed the capital is still there, but it looks like most of the money is headed for Frontline Digitisation. The Highland Marketing advisory board considers how this pattern of putting money into health tech, taking it out again, shaking up the badging, and starting over impacts the market.
Opinion Article by Lord Victor Adebowale CBE, Chair and Co-Dounder of Visionable.
Opinion Article by Professor Ann-Marie Cannaby, senior NHS nurse and member of the BT Clinical Advisory Board, BT Enterprise.
Siemens Healthineers opened a new Ultrasound manufacturing facility in Košice, Slovakia, its first in Europe, with an initial capacity of up to 120 systems per week. The company will use this new facility to expand manufacturing capabilities for its ultrasound products, including the Acuson Sequoia and the Acuson Redwood.
Healthcare professionals at one of the world's leading children's hospitals will benefit from digital imaging tools that will enhance how they assess x-rays, CTs, MRIs and other scans that are crucial for effective diagnoses.
Great Ormond Street Hospital for Children NHS Foundation Trust (GOSH) will deploy an enterprise imaging solution, including a picture archiving and communication system (PACS), from medical imaging technology provider Sectra.
Black Country Pathology Services has seen its "biggest go-live to date" with the Clinisys laboratory information system that is being rolled-out to all of its laboratories.
The Dudley lab had a successful “big bang” go-live with WinPath Enterprise at the end of September and went-live with the Clinisys Integrated Clinical Environment, or ICE, at the same time.
Bayer moves ahead with the advancement of its comprehensive Radiology portfolio with progress on the development pipeline of new contrast agents as well as further partnerships in its digital business. The company announced today the presentation of new early clinical data for gadoquatrane, Bayer’s novel macrocyclic gadolinium-based compound currently in Phase II development, at the Radiological Society of North America (RSNA) Annual Meeting.